HUP0400492A2 - A humán ABC1-gén nukleinsavai és terápiás és diagnosztikai alkalmazásaik - Google Patents

A humán ABC1-gén nukleinsavai és terápiás és diagnosztikai alkalmazásaik

Info

Publication number
HUP0400492A2
HUP0400492A2 HU0400492A HUP0400492A HUP0400492A2 HU P0400492 A2 HUP0400492 A2 HU P0400492A2 HU 0400492 A HU0400492 A HU 0400492A HU P0400492 A HUP0400492 A HU P0400492A HU P0400492 A2 HUP0400492 A2 HU P0400492A2
Authority
HU
Hungary
Prior art keywords
applications
nucleic acids
abc1 gene
human abc1
human
Prior art date
Application number
HU0400492A
Other languages
English (en)
Inventor
Isabelle Arnould-Reguigne
H. Bryan Brewer
Michael Dean
Patrice Denefle
Nicolas Duverger
Michael Jaye
Cendrine Lemoine
Laurent Naudin
Catherine Prades
Alan Remaley
Marie-Francoise Rosier-Montus
George H. Searfoss Iii
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of HUP0400492A2 publication Critical patent/HUP0400492A2/hu
Publication of HUP0400492A3 publication Critical patent/HUP0400492A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
HU0400492A 1999-10-26 2000-10-26 Nucleic acids of the human abc1 gene and applications thereof HUP0400492A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99402668A EP1096012A1 (en) 1999-10-26 1999-10-26 Nucleics acids of the human ABC1 gene and their therapeutic and diagnostic application
US18626000P 2000-03-01 2000-03-01
PCT/EP2000/010886 WO2001030848A2 (en) 1999-10-26 2000-10-26 Nucleic acids of the human abc1 gene and applications thereof

Publications (2)

Publication Number Publication Date
HUP0400492A2 true HUP0400492A2 (hu) 2004-05-28
HUP0400492A3 HUP0400492A3 (en) 2006-01-30

Family

ID=8242152

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0400492A HUP0400492A3 (en) 1999-10-26 2000-10-26 Nucleic acids of the human abc1 gene and applications thereof

Country Status (8)

Country Link
EP (2) EP1096012A1 (hu)
JP (1) JP2003523177A (hu)
AU (1) AU1391901A (hu)
BR (1) BR0014998A (hu)
CA (1) CA2388950A1 (hu)
HU (1) HUP0400492A3 (hu)
WO (1) WO2001030848A2 (hu)
ZA (1) ZA200203269B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6821774B1 (en) 1999-06-18 2004-11-23 Cv Therapeutics, Inc. Compositions and methods for increasing cholesterol efflux and raising HDL using ATP binding cassette transporter ABC1
US6835563B1 (en) 1999-06-18 2004-12-28 Cv Therapeutics Compositions and methods for increasing cholesterol efflux and raising HDL ATP binding cassette transporter protein ABC1
WO2001070810A2 (en) * 2000-03-20 2001-09-27 Bayer Aktiengesellschaft Atp binding cassette transporter 1 (abc1) gene polymorphisms and uses thereof for the diagnosis and treatment of lipid disorders, cardiovascular diseases and inflammatory diseases
WO2002036770A2 (fr) * 2000-10-31 2002-05-10 Aventis Pharma S.A. Sequences polymorphes du gene humain abca1, leurs utilisations, les methodes et kits de detection
FR2815970A1 (fr) * 2000-10-31 2002-05-03 Aventis Pharma Sa Sequences polymorphes du gene humain abca1, leurs utilisations, les methodes et kits de detection
WO2005116057A1 (en) * 2004-05-27 2005-12-08 Baker Medical Research Institute Monoclonal antibody against abca1
WO2006061646A1 (en) * 2004-12-11 2006-06-15 The Science And Technology Facilities Council Assay for generation of a lipid profile using fluorescence measurement
EP2037740A4 (en) * 2006-06-07 2011-12-28 Reddys Lab Ltd Dr COMPOSITIONS AND METHODS FOR IMPROVING THE REVERSE CHOLESTER INTRANSPORT
US20220411880A1 (en) * 2019-11-21 2022-12-29 Inserm (Institut National De La Santéet De La Recherche Médicale) Methods and compositions for diagnosing and treating chronic myelomonocytic leukemia (cmml)

Also Published As

Publication number Publication date
EP1096012A1 (en) 2001-05-02
EP1257651A2 (en) 2002-11-20
CA2388950A1 (en) 2001-05-03
HUP0400492A3 (en) 2006-01-30
WO2001030848A3 (en) 2002-09-12
WO2001030848A2 (en) 2001-05-03
JP2003523177A (ja) 2003-08-05
BR0014998A (pt) 2003-06-17
ZA200203269B (en) 2003-07-24
AU1391901A (en) 2001-05-08

Similar Documents

Publication Publication Date Title
EP1578954A4 (en) 5'-CPG NUCLEIC ACIDS AND USE METHOD
IL147145A0 (en) ANTI-αvβ3 RECOMBINANT HUMAN ANTIBODIES AND NUCLEIC ACIDS ENCODING THE SAME
HK1043150A1 (en) Human delta 5-desaturase gene and uses thereof
AU4341502A (en) Nod2 nucleic acids and proteins
ZA987257B (en) Amplification of nucleic acids
AU2291299A (en) Promoter regions of the mouse and human telomerase rna component genes
GB0002814D0 (en) Nucleic acids and their uses
HUP0400492A3 (en) Nucleic acids of the human abc1 gene and applications thereof
IL128193A0 (en) Rhamnosyl-transferase gene and uses thereof
EP1186615A4 (en) PROTEIN AND DNA OF THIS PROTEIN
AU2735002A (en) Nod2 nucleic acids and proteins
IL149506A0 (en) Human heparanase-related polypeptide and nucleic acid
IL149679A0 (en) Nucleic acid construct and methods utilizing the same
EP1220896A4 (en) NEW HUMANE LIPASE PROTEINS, FOR CODING NUCLEIC ACIDS AND THEIR USE
IL147071A0 (en) Nucleic and proteinic acids corresponding to human gene abc1
EP1240357A4 (en) PROGRESSIVELY TRUNCATED NUCLEIC ACIDS AND PROCESSES FOR PREPARING THEM
EP1241256A4 (en) NEW GENE AND USE
EP1309603A4 (en) NUCLEIC ACIDS COMPRISING PEG-3 PROMOTER REGIONS OF RAT AND USES THEREOF
AU2001266813A1 (en) Human proteins and nucleic acids encoding same
AU2002367841A8 (en) Bsnd nucleic acids and proteins
AU1517500A (en) Nucleic acids and proteins of the human span-x gene and uses thereof
AU4312201A (en) Isolation and purification of nucleic acids
IL149185A0 (en) Nucleic acids of the human abc1 gene and their therapeutic and diagnostic application
EP1189920A4 (en) FAMILY OF GENES CAMELLO AND THE USE OF THE SAID GENES
PL354184A1 (en) The prv-1 gene and use thereof

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees